Colorectal surgery in Italy during the Covid19 outbreak: a survey from the iCral study group.


Journal

Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 01 04 2020
accepted: 03 04 2020
pubmed: 22 5 2020
medline: 22 9 2020
entrez: 22 5 2020
Statut: ppublish

Résumé

The COVID19 pandemic had a deep impact on healthcare facilities in Italy, with profound reorganization of surgical activities. The Italian ColoRectal Anastomotic Leakage (iCral) study group collecting 43 Italian surgical centers experienced in colorectal surgery from multiple regions performed a quick survey to make a snapshot of the current situation. A 25-items questionnaire was sent to the 43 principal investigators of the iCral study group, with questions regarding qualitative and quantitative aspects of the surgical activity before and after the COVID19 outbreak. Two-thirds of the centers were involved in the treatment of COVID19 cases. Intensive care units (ICU) beds were partially or totally reallocated for the treatment of COVID19 cases in 72% of the hospitals. Elective colorectal surgery for malignancy was stopped or delayed in nearly 30% of the centers, with less than 20% of them still scheduling elective colorectal resections for frail and comorbid patients needing postoperative ICU care. A significant reduction of the number of colorectal resections during the time span from January to March 2020 was recorded, with significant delay in treatment in more than 50% of the centers. Our survey confirms that COVID19 outbreak is severely affecting the activity of colorectal surgery centers participating to iCral study group. This could impact the activity of surgical centers for many months after the end of the emergency.

Sections du résumé

BACKGROUND BACKGROUND
The COVID19 pandemic had a deep impact on healthcare facilities in Italy, with profound reorganization of surgical activities. The Italian ColoRectal Anastomotic Leakage (iCral) study group collecting 43 Italian surgical centers experienced in colorectal surgery from multiple regions performed a quick survey to make a snapshot of the current situation.
METHODS METHODS
A 25-items questionnaire was sent to the 43 principal investigators of the iCral study group, with questions regarding qualitative and quantitative aspects of the surgical activity before and after the COVID19 outbreak.
RESULTS RESULTS
Two-thirds of the centers were involved in the treatment of COVID19 cases. Intensive care units (ICU) beds were partially or totally reallocated for the treatment of COVID19 cases in 72% of the hospitals. Elective colorectal surgery for malignancy was stopped or delayed in nearly 30% of the centers, with less than 20% of them still scheduling elective colorectal resections for frail and comorbid patients needing postoperative ICU care. A significant reduction of the number of colorectal resections during the time span from January to March 2020 was recorded, with significant delay in treatment in more than 50% of the centers.
DISCUSSION CONCLUSIONS
Our survey confirms that COVID19 outbreak is severely affecting the activity of colorectal surgery centers participating to iCral study group. This could impact the activity of surgical centers for many months after the end of the emergency.

Identifiants

pubmed: 32436016
doi: 10.1007/s13304-020-00760-3
pii: 10.1007/s13304-020-00760-3
pmc: PMC7238958
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-257

Références

Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):208-211
pubmed: 32192295
Ann Surg. 2020 Jul;272(1):e1-e2
pubmed: 32209891
Updates Surg. 2020 May 12;:
pubmed: 32399595
Ann Surg. 2020 Apr 17;:
pubmed: 32379080
World J Emerg Surg. 2020 Apr 7;15(1):25
pubmed: 32264898
BJS Open. 2020 Jun;4(3):499-507
pubmed: 32134216
BMJ. 2015 Apr 09;350:h694
pubmed: 25858901
Occup Environ Med. 2016 Dec;73(12):857-863
pubmed: 27484956
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Lancet Respir Med. 2020 Mar;8(3):e13
pubmed: 32061333
J Healthc Eng. 2016;2016:
pubmed: 27195721
JSLS. 2014 Jul-Sep;18(3):
pubmed: 25392644
Br J Surg. 2020 Jun;107(7):785-787
pubmed: 32191340
Updates Surg. 2019 Jun;71(2):339-347
pubmed: 30747374

Auteurs

Marco Caricato (M)

Colorectal Surgery Unit, Campus BioMedico University Hospital, Rome, Italy.

Gian Luca Baiocchi (GL)

General Surgery Unit 3, University and Spedali Civili, Brescia, Italy.

Francesco Crafa (F)

General and Oncologic Surgery Unit, Moscati Hospital, Avellino, Italy.

Stefano Scabini (S)

General and Oncologic Surgery Unit, National Cancer Center "San Martino", Genoa, Italy.

Giuseppe Brisinda (G)

General Surgery Unit, San Giovanni di Dio Hospital, Crotone, Italy.

Marco Clementi (M)

General Surgery Unit, University Hospital, L'Aquila, Italy.

Giuseppe Sica (G)

General Surgery Unit, Tor Vergata University Hospital, Rome, Italy.

Paolo Delrio (P)

Colorectal Surgical Oncology Unit, IRCCS G. Pascale Foundation, Naples, Italy.

Graziano Longo (G)

General Surgery Unit, Policlinico Casilino, Rome, Italy.

Gabriele Anania (G)

General Surgery Unit, University Hospital, Ferrara, Italy.

Nicolò de Manzini (N)

General Surgery Unit, University Hospital, Trieste, Italy.

Pietro Amodio (P)

General Surgery Unit, Belcolle Hospital, Viterbo, Italy.

Andrea Lucchi (A)

General Surgery Unit, Ceccarini Hospital, Riccione, RN, Italy.

Gianandrea Baldazzi (G)

General Surgery Unit, ASST Nord Hospital, Sesto San Giovanni, MI, Italy.

Gianluca Garulli (G)

General Surgery Unit, Infermi Hospital, Rimini, Italy.

Alberto Patriti (A)

General Surgery Unit, Marche Nord Hospital, Pesaro e Fano, PU, Italy.

Felice Pirozzi (F)

General Surgery Unit, ASL Napoli2 Hospital, Pozzuoli, NA, Italy.

Maurizio Pavanello (M)

General Surgery Unit, AULSS2 Hospital, Conegliano Veneto, TV, Italy.

Alessandro Carrara (A)

General Surgery Unit, Santa Chiara Hospital, Trento, Italy.

Roberto Campagnacci (R)

General Surgery Unit, C. Urbani Hospital, Jesi, AN, Italy.

Andrea Liverani (A)

General Surgery Unit, Regina Apostolorum Hospital, Albano Laziale, RM, Italy.

Andrea Muratore (A)

General Surgery Unit, E. Agnelli Hospital, Pinerolo, TO, Italy.

Walter Siquini (W)

General Surgery Unit, ASUR AV3 Hospital, Macerata, Italy.

Raffaele De Luca (R)

Surgical Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.

Stefano Mancini (S)

General and Oncologic Surgery Unit, San Filippo Neri Hospital, Rome, Italy.

Felice Borghi (F)

General Surgery Unit, Santa Croce e Carle Hospital, Cuneo, Italy.

Mariantonietta Di Cosmo (M)

General Surgery Unit - Upper GI, University Hospital, Verona, Italy.

Roberto Persiani (R)

General Surgery Unit, Catholic University Hospital, Rome, Italy.

Corrado Pedrazzani (C)

General Surgery Unit - Lower GI, University Hospital, Verona, Italy.

Matteo Scaramuzzi (M)

General Surgery Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy.

Marco Scatizzi (M)

General Surgery Unit, Santa Maria Annunziata Hospital, Firenze, Italy.

Nereo Vettoretto (N)

General Surgery Unit, Spedali Civili of Brescia, Montichiari, BS, Italy.

Mauro Totis (M)

General Surgery Unit, San Gerardo Hospital, Monza, Italy.

Andrea Gennai (A)

General Surgery Unit, Sant'Andrea Hospital, La Spezia, Italy.

Pierluigi Marini (P)

General Surgery Unit, San Camillo Hospital, Roma, Italy.

Massimo Basti (M)

General Surgery Unit, Santo Spirito Hospital, Pescara, Italy.

Massimo Viola (M)

General Surgery Unit, Cardinale Panico Hospital, Tricase, LE, Italy.

Giacomo Ruffo (G)

General Surgery Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.

Marco Catarci (M)

General Surgery Unit, Ospedale "C. E G. Mazzoni", ASUR Marche AV5, Via degli Iris snc, 63100, Ascoli Piceno, Italy. marco.catarci@sanita.marche.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH